Top compounds associated with response to SPRY2


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA lapatinib gCSI pan-cancer AAC -0.12 0.07
mRNA QW-BI-011 CTRPv2 pan-cancer AAC -0.12 0.1
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.12 0.0009
mRNA GW-2580 GDSC1000 pan-cancer AAC -0.12 0.002
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.12 0.0007
mRNA AZD6244 UHNBreast pan-cancer AAC -0.12 0.7
mRNA Axitinib FIMM pan-cancer AAC -0.12 0.5
mRNA JW-55 CTRPv2 pan-cancer AAC -0.11 0.2
mRNA A-443654 GDSC1000 pan-cancer AAC -0.11 0.05
Download CSV